Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common variable immunodeficiency: clinical aspects and recent progress in identifying the immunological defect(s)

M M Eibl1, H M Wolf

  • 1Institute of Immunology, University of Vienna.

Folia Microbiologica
|January 1, 1995
PubMed
Summary

Common variable immunodeficiency (CVID) is characterized by low immunoglobulin levels and poor antibody production, leading to recurrent infections. Early diagnosis and intravenous IgG (IVIG) therapy are crucial for managing CVID and preventing complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Heterozygous promotor haplotype LXA/LYB in MBL-deficiency associated with myopathy and left ventricular hypertrabeculation/noncompaction.

Irish journal of medical science·2009
Same author

Intravenous immunoglobulins in neurological disorders: safety issues.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2003
Same author

Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2003
Same author

Residual expression of functional MHC class II molecules in twin brothers with MHC class II deficiency is cell type specific.

British journal of haematology·2001
Same author

Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.

European journal of gastroenterology & hepatology·2001

Area of Science:

  • Immunology
  • Clinical Medicine

Background:

  • Common variable immunodeficiency (CVID) presents as a diverse condition with unknown genetic causes.
  • Patients exhibit reduced immunoglobulin levels and impaired antibody synthesis, resulting in recurrent respiratory and gastrointestinal infections.
  • These infections can lead to severe organ damage, including chronic pulmonary disease and failure.

Purpose of the Study:

  • To investigate the underlying immunological defects in patients with Common variable immunodeficiency (CVID).
  • To explore the role of T-cell activation and T-B-cell interaction in the pathogenesis of CVID.
  • To understand the mechanisms behind impaired antibody production in CVID patients.

Main Methods:

  • Review of existing literature on CVID pathophysiology.

Related Experiment Videos

  • Analysis of immunological data from CVID patient subgroups.
  • Examination of T-cell signaling pathways and B-cell interaction markers, including CD40 ligand and cytokine production.

    • Main Results:

    • A significant subgroup of CVID patients shows defective T-cell activation due to impaired signal transduction.
    • This T-cell defect may compromise T-B-cell interactions, potentially through altered CD40 ligand expression or abnormal cytokine profiles.
    • Evidence does not strongly support an intrinsic B-cell defect as the primary cause of CVID.

    Conclusions:

    • The primary immunological defect in many CVID patients appears to be related to T-cell activation rather than intrinsic B-cell dysfunction.
    • Impaired T-cell function can disrupt essential T-B-cell interactions, explaining the characteristic antibody deficiency in CVID.
    • Further research into T-cell defects is crucial for understanding and potentially improving CVID treatment strategies.